Skip to main content
. Author manuscript; available in PMC: 2019 Feb 16.
Published in final edited form as: ACS Chem Biol. 2018 Jan 17;13(2):455–460. doi: 10.1021/acschembio.7b00883

Figure 1.

Figure 1.

A CRISPR-Cas9 transcriptional reporter of KAT activity. (a) Scheme for induction of acetylation/gene expression by dCas9-p300, first reported by Gersbach et al. (b) Domain architecture of dCas9-p300 fusion. (c) Activation of model inducible genes IL1RN, RHOXF2, and TTN by dCas9-p300 in HEK-293 cells. D1399Y refers to a dCas9-p300 construct harboring a mutation to the KAT catalytic domain.